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INTRODUCTION:  Heparin-induced  thrombocytopenia  (HIT)  is  a rare but serious  condition  due  to  heparin
use  for  treating  thromboprophylaxis,  regardless  of  the  dosage.  Here,  we  present a case  of  non-immune
thrombocytopenia  caused  by  thromboprophylaxis  for urological  surgery,  which  is  sometimes  difﬁcult  to
discriminate  from  immune-mediated  thrombocytopenia.
PRESENTATION  OF  CASE:  A 55-year-old  man  with  renal  cancer  underwent  portless  endoscopic  radical
nephrectomy  through  a single  small  incision  and  was subsequently  administered  unfractionated  heparin
as well  as mechanical  devices  to  prevent  venous  thromboembolism.  On postoperative  day  2, a subcuta-
neous  hemorrhage  developed  around  the surgical  site  and  the  lower  abdomen,  and  the platelet  count
simultaneously  decreased  to 50%  of  the  baseline  value.  We  suspected  HIT  and  immediately  conducted
the  4Ts  score  examination.  The  4Ts  score  was  3  points  (low  probability),  and  the  result  of  the  platelet
factor  4-heparin  complex  antibody  assay  was  negative.  The  patient  was diagnosed  with  non-immune
mediated  thrombocytopenia.  We  took  precaution  by  discontinuing  heparin,  which  fortunately  did not
result  in  any  adverse  effects,  and  this  led to platelet  count  normalization.
DISCUSSION:  Due  to the rarity  of  HIT,  it is difﬁcult  to distinguish  HIT  from  non-immune  mediated  throm-
bocytopenia.
CONCLUSION:  This  article  emphasizes  that  early  and accurate  diagnosis  of  postoperative  thrombocytope-
nia  is  important  for accurate  therapy.  Hence,  all surgeons  should  know  that  the  HIT  diagnosis  is based  on
clinical  and serologic  ﬁndings.
© 2016  The  Authors.  Published  by  Elsevier  Ltd  on  behalf  of  IJS Publishing  Group  Ltd.  This is  an  open
he  CCaccess  article  under  t
. Introduction
Venous thromboembolism (VTE) is one of the most common
auses of perioperative nonsurgical death. The American Urological
ssociation published a statement on perioperative VTE preven-
ion for urological surgeries, in which unfractionated heparin (UFH)
nd low molecular weight heparin (LMWH) are recommended
or thromboprophylaxis [1]. Heparin-induced thrombocytopenia
HIT) is a rare but serious adverse event that occurs in 1–5%
f patients who are administered a perioperative thrombopro-
hylactic dose of heparin. The dose is typically lower than that
or therapeutic use, but the incidence of HIT is reported to be
Abbreviations: HIT, heparin-induced thrombocytopenia; VTE, venous throm-
oembolism; UFH, unfractionated heparin; LMWH,  low molecular weight heparin;
UA, American Urological Association.
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ttp://dx.doi.org/10.1016/j.ijscr.2016.07.049
210-2612/© 2016 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing G
reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
more frequent [2]. HIT can lead to thromboembolic complications,
including pulmonary thromboembolism, ischemic limb necrosis,
acute myocardial infarction, and stroke [3]. The two  types of HIT
are distinguishable by pathophysiologic mechanisms and clinical
characteristics. Type 1 HIT arises via a non-immunologic mecha-
nism within a few days after exposure to heparin. It is characterized
by a mild thrombocytopenia that requires careful monitoring but
typically not the cessation of heparin therapy [4]. Type 2, i.e.
immune-mediated thrombocytopenia, is caused by the develop-
ment of IgG antibodies directed against a complex of PF4 and
heparin, and it is characterized by a major decrease in platelet
count and paradoxical hypercoagulable state caused by platelet
activation and associated thrombin generation [5]. Thrombosis
occurs more frequently in patients with type 2 HIT, and type 2
requires more severe management than type 1. Therefore, the
term “HIT” has been more generally used to describe type 2 but
not type 1. Overlooking or misdiagnosing HIT, conversely, may
result in serious adverse events or exposure of thrombocytopenic
patients to alternative anticoagulants and unnecessary suspension
of heparin. Herein, we report a case of non-immune-mediated
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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aig. 1. A computed tomography showed a 3 × 3 cm enhanced solid lesion in the
iddle of the right kidney.
hrombocytopenia caused by the thromboprophylactic use of hep-
rin after urological surgery.
. Presentation of case
A 55-year-old man  was referred to our hospital for the treat-
ent of a right renal tumor. Computed tomography (CT) showed a
.0-cm hypervascular tumor without any metastasis in his right
idney (Fig. 1). The patient had not received heparin treatment
n the past. A portless endoscopic radical nephrectomy through
 single small incision was  performed, resulting in 40 mL  of esti-
ated blood loss, and the histological diagnosis was pT1a, clear
ell renal cell carcinoma [6,7]. The patient was prescribed mechan-
cal thromboprophylaxis until he achieved full ambulatory status,
nd 5000 units of UFH were administered twice a day subcuta-
eously, initiated 3 h after surgical closure. He was not prescribed
ny other drugs (i.e., chemotherapy, linezolid, or bortezomib) that
ould cause thrombocytopenia by non-immune mechanisms peri-
peratively. On postoperative day 2, a subcutaneous hemorrhage
eveloped around the surgical site and the lower abdomen (0 points
or the Timing and Thrombosis elements of the 4Ts score) (Fig. 2).
is platelet count decreased to 50% of the baseline value (nadir,
9 × 109/L, 2 points for the Thrombocytopenia element of the 4Ts
core) after a secondary injection of 5000 units of UFH, although
t was 164 × 109/L, which was within the normal level, preoper-
tively. There were other possible causes for thrombocytopenia,
Fig. 2. Subcutaneous hemorrhage around thPEN  ACCESS
gery Case Reports 27 (2016) 21–23
including the consumption of platelets due to surgical invasion (1
point in the oTher element of the 4Ts score). The 4Ts score, which
is the most reliable tool for clinically suspected HIT, was  3 points,
equating to a low probability level, and the patient did not have
skin lesions at the heparin injection sites or an acute systemic
reaction [3]. The platelet factor 4 (PF4)-heparin complex antibody
assay was  negative. Multidetector-row CT and color Doppler ultra-
sonography did not show any thrombosis. Based on these ﬁndings,
the patient was  not diagnosed with HIT, but he was diagnosed
with non-immune mediated thrombocytopenia due to heparin. We
decided to discontinue anticoagulation therapy because the patient
was fully ambulatory, and the platelet count promptly increased to
173 × 109/L after discontinuation of UFH.
3. Discussion
Immune-mediated HIT is an adverse drug reaction that can lead
to devastating thromboembolic complications, even when using
heparin for perioperative thromboprophylaxis. It occurs when a
complex between IgG antibodies and PF4-heparin forms. The anti-
bodies activate platelets by binding to the FcIIa receptor, resulting
in systemic thrombosis and consumptive thrombocytopenia [8].
On the other hand, the prevention of thromboembolism asso-
ciated with surgical procedures is a necessary consideration for
surgeons by using anti-coagulation agents, such as heparin, aspirin,
and warfarin, because thromboembolism is a perioperative life-
threatening event [9]. Accordingly, the AUA and American College
of Chest Physicians guidelines recommend prescription of pharma-
cological thromboprophylaxis in addition to mechanical devices
postoperatively [1,3]. In such a situation, we  encountered a case
of non-immune mediated thrombocytopenia, which we  distin-
guished from HIT, in perioperative thromboprophylaxis.
The diagnosis of HIT requires a combination of clinical assess-
ment and immunoassay results. The 4Ts score, which is currently
considered the most reliable tool, is derived using 4 elements: the
degree of Thrombocytopenia, Timing of platelet count decrease
or thrombosis, Thrombosis or other clinical sequelae, and oTher
causes of thrombocytopenia [3]. Cuker et al. reported a systemic
review and meta-analysis of 13 eligible studies evaluating the
predictive value of the 4Ts scoring system. The negative predic-
tive value of a low probability 4Ts score (≤3) was 0.998 (95% CI,
0.970–1.000), and the positive predictive values of intermediate
and high probability (≥4) 4Ts scores were 0.14 (0.09–0.22) and
0.64 (0.40–0.82), respectively [8]. Thus, they proposed that a low
probability 4Ts score is a way to exclude HIT, and alternative diag-
noses, including non-immune mediated thrombocytopenia, should
be considered for patients with low 4Ts scores [10]. Additionally,
they described the possibility of missing patients with true HIT
despite a low probability 4Ts score.
e surgical site and the lower abdomen.
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To conﬁrm the diagnosis of HIT, immunoassays are also
equired, of which there are two major categories: functional assays
hat detect evidence of platelet activation by HIT antibodies and
ntigen assays that detect the presence of HIT antibodies. Func-
ional assays, such as the heparin-induced platelet activation and
erotonin release assays, have high sensitivity and speciﬁcity. How-
ver, they require radioisotope and reactive donor platelets, which
re reagents that are unfeasible for most clinical laboratories owing
o the time and labor involved. Consequently, such assays are avail-
ble to the majority of clinicians only as “send-out” tests and do
ot yield results in a timeframe necessary to inform initial clinical
ecision-making [3,10]. We  used the antigen assay, for which the
ensitivity is very high while the speciﬁcity is moderate, because it
as the only available assay in our institute.
The American College of Chest Physicians recommends the
se of argatroban, lepirudin, or danaparoid, rather than further
se of heparin, LMWH,  or initiation/continuation of a vitamin K
ntagonist, with or without thrombosis (Grade 1C), when treat-
ng HIT [3]. In contrast, non-immune-mediated thrombocytopenia
s usually mild and transient. It is a benign condition not asso-
iated with risk thrombosis. The present case was diagnosed as
on-immune-mediated thrombocytopenia because of the results of
Ts score and immunoassay. Although our patient’s platelet levels
romptly recovered upon discontinuation of UFH with monitor-
ng and mechanical thromboprophylaxis, there might be no need
o discontinue heparin for non-immune-mediated thrombocytope-
ia.
A comprehensive MEDLINE search resulted in only 3 cases
eports within the medical literature of HIT during urological
urgery [8,11,12]. Consequently, urologists are not usually famil-
ar with the management of and the principles for treating this
ondition. One reported case involved transurethral resection of
he prostate for benign prostatic hyperplasia, and the 4Ts score
nd immunoassays were not implemented for diagnosis. The other
ases involved a partial nephrectomy for renal cancer and Fournier
angrene. HIT was detected in those cases after diagnosis of
 bilateral adrenal hemorrhage after more than 5 days of hep-
rin administration without calculation of the 4Ts score. One of
hese 3 cases were diagnosed after PF4-heparin complex anti-
ody detection. However, the others were diagnosed without the
mmunoassays.
The implementation of diagnostic methods for HIT appears to
e insufﬁcient. Surgeons should consider HIT when heparin is used
or perioperative thromboprophylaxis and perform the necessary
xaminations immediately if suspected. Otherwise, this serious
omplication due to heparin use might be overlooked.
. Conclusion
We  diagnosed the patient described here with non-immune
ediated thrombocytopenia and not HIT because of the 4Ts score
nd negative antigen assay results. This article emphasizes the need
or early and accurate diagnosis of postoperative thrombocytope-
ia in order to accurately treat patients. Hence, all surgeons should
now the HIT diagnosis is based on clinical and serologic ﬁndings.onﬂicts of interest
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